Detalhe da pesquisa
1.
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
Ann Oncol
; 29(8): 1843-1852, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30010756
2.
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
Ann Oncol
; 30(12): 2013-2014, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430371